Biotech
AmplifyBio
AmplifyBio raises $50M Growth at $280M valuation
$50M
Total Raised
Growth
Latest Round
2020
Founded
400+
Employees
New Albany, OH
1 min read
Quick Facts
Valuation
$280M
Latest Round Size
$50M
Latest Round Date
November 2024
AmplifyBio: Growth Funding Round
AmplifyBio has successfully raised $50M in Growth funding, reaching a valuation of $280M.
Company Overview
Drug development company providing preclinical and clinical services
Funding Details
The Growth round was led by Vitrian, with participation from Safar Partners.
Company Information
- Headquarters: New Albany, OH
- Founded: 2020
- Employees: 400+
- Category: Biotech
Investment
AmplifyBio plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Vitrian: Verified investor in Growth
- Safar Partners: Verified investor in Growth
Key Investors
Vitrian
Lead Investor
Verified investor in Growth
Safar Partners
Investor
Verified investor in Growth
About the Author
Editorial Team
Curated funding news from verified sources
Related Company Reports
Biotech
Orna Therapeutics
Orna Therapeutics Raises $251M Series B
Biotechnology company developing circular RNA therapeutics for cancer, genetic diseases, and infectious diseases
Emma Rodriguez
Oct 23, 2025
0 min read•$251M Series B
Biotech
Forge Biologics
Forge Biologics Raises $120M Series C
Gene therapy CDMO providing manufacturing and development services for AAV-based genetic medicines
Sarah Kim
Oct 23, 2025
0 min read•$120M Series C
Biotech
Vir Biotechnology
Vir Biotechnology Raises $250M
Clinical-stage immunology company developing treatments for infectious diseases including COVID-19, hepatitis B, and influenza
Sarah Kim
Oct 23, 2025
0 min read•$250M